Introduction Fexofenadine Hydrochloride, a second-generation antihistamine widely used in the treatment of allergic conditions such as hay fever and chronic urticaria, plays a vital role in the global pharmaceutical industry. As an active pharmaceutical ingredient (API), its pricing dynamics are influenced by a complex interplay of raw material availability, production costs, regulatory frameworks, and regional demand-supply balances. In Q3 2025, the globalĀ Fexofenadine Hydr
